APOL.AQ - Apollon Formularies PLC

Aquis AQSE - Aquis AQSE Delayed price. Currency in GBp (0.01 GBP)
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
Total revenue
-2
-2
2,217
Cost of revenue
-
-384
1,959
Gross profit
-
382
258
Operating expenses
Selling general and administrative
373.341
52
411
Total operating expenses
373.341
52
434
Operating income or loss
8.659
330
-176
Interest expense
-
-
4
Income before tax
-975.21
330
-2,480
Income tax expense
0
-
-
Income from continuing operations
-975.21
330
-2,480
Net income
-975.21
330
-2,480
Net income available to common shareholders
-975.21
330
-2,480
Basic EPS
-
0.01
-0.10
Diluted EPS
-
0.01
-0.10
Basic average shares
-
31,710
25,410
Diluted average shares
-
32,900
25,410
EBITDA
-
330
-2,475